MCM
AUTL

MAI Capital Management’s Autolus Therapeutics AUTL Stock Holding History

MAI Capital Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-189
Closed -$261 – 2289
2026
Q1 		$261 Hold
189
– – ﹤0.01% 4559
2025
Q4 		$377 Sell
189
-3,909
-95% -$6.01K ﹤0.01% 3909
2025
Q3 		$6.68K Sell
4,098
-17,136
-81% -$33.5K ﹤0.01% 2913
2025
Q2 		$48.4K Sell
21,234
-12,632
-37% -$20.9K ﹤0.01% 1877
2025
Q1 		$52.5K Sell
33,866
-294,460
-90% -$598K ﹤0.01% 1719
2024
Q4 		$772K Sell
328,326
-913
-0.3% -$3.09K 0.01% 717
2024
Q3 		$1.2M Sell
329,239
-4,761
-1% -$19K 0.01% 507
2024
Q2 		$1.16M Sell
334,000
-20,306
-6% -$87.6K 0.01% 556
2024
Q1 		$2.26M Buy
354,306
+2,400
+0.7% +$15K 0.02% 380
2023
Q4 		$2.27M Sell
351,906
-17,574
-5% -$67K 0.03% 302
2023
Q3 		$861K Sell
369,480
-32,016
-8% -$91.2K 0.01% 467
2023
Q2 		$956K Sell
401,496
-32,169
-7% -$76.3K 0.01% 444
2023
Q1 		$798K Sell
433,665
-48,987
-10% -$95.8K 0.01% 483
2022
Q4 		$917K Buy
482,652
+123,542
+34% +$312K 0.02% 429
2022
Q3 		$768K Sell
359,110
-6,297
-2% -$18.7K 0.01% 428
2022
Q2 		$1.03M Buy
+365,407
New +$1.11M 0.02% 365

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAI Capital Management's AUTL Position: Q2 2026 in Review

MAI Capital Management sold out of Autolus Therapeutics (AUTL) in Q2 2026, closing a stake of 189 shares — an estimated $261 sold.

MAI Capital Management first reported a position in AUTL in Q2 2022 and held it in 16 quarters. The position peaked at $2.27M in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • MAI Capital Management reported no remaining Autolus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 189 Autolus Therapeutics shares in Q2 2026, an estimated $261.
  • MAI Capital Management first reported a position in Autolus Therapeutics in Q2 2022 and held it in 16 quarters.
  • MAI Capital Management's Autolus Therapeutics position peaked at $2.27M in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.